Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of dried blood spot analysis for antituberculosis drug monitoring
NL-OMON34891Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of isoniazid, rifampicin, ethambutol, pyrazinamide, amikacin and 4 more in Tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB), sponsored by University Medical Center Groningen. Started Oct 2010; status: active, not recruiting.
02
Drugs
isoniazidrifampicinethambutolpyrazinamideamikacin
03
Conditions
Tuberculosis (TB)multidrug-resistant tuberculosis (MDR-TB)
Beyond the preview
Go deeper on NL-OMON34891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34891.